(Q44304779)

1 December 2017

Recent Developments in Epidemiology, Treatment, and Diagnosis of Tuberculosis (English)

1 reference

1 December 2017

1 reference

Hamilton CD

1

1 reference

1 December 2017

1 April 1999

1 reference

Current infectious disease reports

1 December 2017

1 reference

1 December 2017

1

1 reference

1 December 2017

1

1 reference

1 December 2017

80-88

1 reference

Tuberculosis control policies in major metropolitan health departments in the United States. VI. Standard of practice in 1996.

1 December 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0014-6

Use of DNA fingerprinting to assess tuberculosis infection control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0014-6

Movement of tuberculosis patients and the failure to complete antituberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0014-6

Why do symptomatic patients delay obtaining care for tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0014-6

The host immune response to tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0014-6

Predictive value of contact investigation for identifying recent transmission of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0014-6

Differences in contributing factors to tuberculosis incidence in U.S. -born and foreign-born persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0014-6

Once-weekly rifapentine-containing regimens for treatment of tuberculosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0014-6

Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0014-6

Accelerated course of human immunodeficiency virus infection after tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0014-6

The clinical pharmacokinetics of rifabutin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0014-6

Antimicrobial activity of rifabutin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0014-6

Use of rifabutin in the treatment of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0014-6

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0014-6

The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0014-6

The incidence of false-positive cultures for Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0014-6

Two-step tuberculin skin testing in HIV-infected persons in Uganda.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-999-0014-6

Automatable radiometric detection of growth of Mycobacterium tuberculosis in selective media

21 January 2018

1 reference

12 December 2020

The in vitro induction of human immunodeficiency virus (HIV) replication in purified protein derivative-positive HIV-infected persons by recall antigen response to Mycobacterium tuberculosis is the result of a balance of the effects of endogenous in

1 reference

12 December 2020

Bioavailability of Chinese rifapentine during a clinical trial in Hong Kong

1 reference

12 December 2020

Tuberculosis and race/ethnicity in the United States: impact of socioeconomic status

1 reference

12 December 2020

The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs

1 reference

12 December 2020

Association between an early humoral response to Mycobacterium tuberculosis antigens and later development of tuberculosis in human immunodeficiency virus-infected individuals

1 reference

12 December 2020

Trends in drug-resistant tuberculosis in the United States, 1993-1996

1 reference

12 December 2020

Long-term hospitalization for tuberculosis control. Experience with a medical-psychosocial inpatient unit

1 reference

12 December 2020

The evolving relation between humans and Mycobacterium tuberculosis

1 reference

12 December 2020

Rifabutin for the treatment of newly-diagnosed pulmonary tuberculosis: a multinational, randomized, comparative study versus Rifampicin. Rifabutin Study Group

1 reference

12 December 2020

Results of tuberculosis contact tracing: Blackburn 1982-90

1 reference

12 December 2020

Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months

1 reference

12 December 2020

Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans

1 reference

12 December 2020

Current issues in the pathogenesis and management of HIV-related tuberculosis

1 reference

12 December 2020

A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosis

1 reference

12 December 2020

Diagnostic mycobacteriology: where are we today?

1 reference

12 December 2020

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

12 December 2020

Control of tuberculosis in the United States. American Thoracic Society

1 reference

12 December 2020

A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team

1 reference

12 December 2020

Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis. Initial report

1 reference

12 December 2020

Molecular and geographic patterns of tuberculosis transmission after 15 years of directly observed therapy

1 reference

12 December 2020

Methods for diagnosing tuberculosis among in-patients in eastern Africa whose sputum smears are negative

1 reference

12 December 2020

The validity of classic symptoms and chest radiographic configuration in predicting pulmonary tuberculosis

1 reference

12 December 2020

Anergy skin testing and tuberculosis [corrected] preventive therapy for HIV-infected persons: revised recommendations. Centers for Disease Control and Prevention

1 reference

12 December 2020

Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection

1 reference

12 December 2020

Recommendations for prevention and control of tuberculosis among foreign-born persons. Report of the Working Group on Tuberculosis among Foreign-Born Persons. Centers for Disease Control and Prevention

1 reference

12 December 2020

Transmission of Tuberculosis in New York City -- An Analysis by DNA Fingerprinting and Conventional Epidemiologic Methods

1 reference

12 December 2020

An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection

1 reference

12 December 2020

Acquired drug resistance in Mycobacterium tuberculosis isolates recovered from compliant patients with human immunodeficiency virus-associated tuberculosis

1 reference

12 December 2020

Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel

1 reference

12 December 2020

The use of restriction fragment length polymorphism (RFLP) analysis for epidemiological studies of tuberculosis in developing countries

1 reference

12 December 2020

Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention

1 reference

12 December 2020

The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods

1 reference

12 December 2020

Whole blood cytokine assays--a new generation of diagnostic tests for tuberculosis?

1 reference

12 December 2020

Low antituberculosis drug concentrations in patients with AIDS.

1 reference

12 December 2020

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

1 reference

12 December 2020

Dual skin testing with Mycobacterium avium sensitin and purified protein derivative to discriminate pulmonary disease due to M. avium complex from pulmonary disease due to Mycobacterium tuberculosis.

1 reference

12 December 2020

Pharmacokinetics of antimycobacterial drugs in patients with tuberculosis, AIDS, and diarrhea

1 reference

12 December 2020

The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993

1 reference

12 December 2020

Sensitivity and specificity of a gamma interferon blood test for tuberculosis infection

1 reference

12 December 2020

Long-term risk of tuberculosis among foreign-born persons in the United States

1 reference

12 December 2020

Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire

1 reference

12 December 2020

Regulation of the human immune response during tuberculosis.

1 reference

12 December 2020

Tuberculosis infection and disease among persons seeking social services in New York City.

1 reference

12 December 2020

Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel

1 reference

12 December 2020

Two-year follow-up of persons with HIV-1- and HIV-2-associated pulmonary tuberculosis treated with short-course chemotherapy in West Africa

1 reference

12 December 2020

Tuberculosis transmission in the 1990s

1 reference

12 December 2020

The fall after the rise: Tuberculosis in the United States, 1991 through 1994

1 reference

12 December 2020

Development of rifapentine: the way ahead

1 reference

12 December 2020

A nosocomial outbreak of multidrug-resistant tuberculosis

1 reference

12 December 2020

Role of antigen specific circulating immune complexes in diagnosis of tuberculosis.

1 reference

12 December 2020

Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial.

1 reference

12 December 2020

Comparative evaluation of initial and new versions of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens.

1 reference

12 December 2020

Skin testing for tuberculosis in university teaching hospitals--is there a problem?

1 reference

12 December 2020

Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clini

1 reference

12 December 2020

Molecular fingerprinting of Mycobacterium tuberculosis: how can it help the clinician?

1 reference

12 December 2020

Tuberculosis: commentary on a reemergent killer

1 reference

12 December 2020

Rapid diagnostic tests for tuberculosis: what is the appropriate use? American Thoracic Society Workshop

1 reference

12 December 2020

Are US hospitals making progress in implementing guidelines for prevention of Mycobacterium tuberculosis transmission?

1 reference

12 December 2020

Variation of chest radiographic patterns in pulmonary tuberculosis by degree of human immunodeficiency virus-related immunosuppression. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). The AIDS Clinical Trials Group (ACTG).

1 reference

12 December 2020

10.1007/S11908-999-0014-6

Identifiers

DOI

1 reference

1 December 2017

1 reference

PubMed ID

11095771